CLINICAL SKILLS - PART 4 pot

Cahiers de nutrition diététique - part 4 potx

Cahiers de nutrition diététique - part 4 potx

... 10 ans d’évolution d nutrition aggra- vée d’hypokaliémie. Au cours de la phase de sortie de la dénu- trition, quand la malade aura accepté de reprendre du poids, des crises de boulimie peuvent ... dans la mortalité par mort violente (25 % des accidents de la circulation, 10 % des accidents du travail, 25 % des suicides et plus de 50 % des homicides volontaires). La mortalité li...
Ngày tải lên : 18/06/2014, 10:05
  • 16
  • 369
  • 0
Chapter 064. The Practice of Genetics in Clinical Medicine (Part 4) potx

Chapter 064. The Practice of Genetics in Clinical Medicine (Part 4) potx

... to note that, for the majority of adult-onset, multifactorial genetic Chapter 064. The Practice of Genetics in Clinical Medicine (Part 4) Figure 64-2 disorders, testing is purely predictive. ... established disease, genetic testing for susceptibility to chronic disease is being increasingly integrated into the practice of medicine. In most cases, h...
Ngày tải lên : 07/07/2014, 01:20
  • 5
  • 429
  • 0
Chapter 067. Applications of Stem Cell Biology in Clinical Medicine (Part 4) pot

Chapter 067. Applications of Stem Cell Biology in Clinical Medicine (Part 4) pot

... Essentials of Stem Cell Biology. San Diego, Elsevier Chapter 067. Applications of Stem Cell Biology in Clinical Medicine (Part 4) Other Organ Systems and the Future The use of stem cells in regenerative ... Biomedical Applications of Stem Cell Research et al: Stem Cells and the Future of Regenerative Medicine. Washington, D.C., Nati...
Ngày tải lên : 07/07/2014, 01:20
  • 5
  • 311
  • 0
Neuroimmunology in Clinical Practice - part 4 pot

Neuroimmunology in Clinical Practice - part 4 pot

... 1993. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology, 43 (4) , 655–61. The ... Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group. 2001. Randomized controlled trial of interferon-beta-1a in secondary progres...
Ngày tải lên : 10/08/2014, 00:20
  • 27
  • 483
  • 0
Atlas of Clinical Hematology - part 4 potx

Atlas of Clinical Hematology - part 4 potx

... and paucity of fat cells d Histologic section during chronic phase of CML. Naphthol AS-D chloro- acetate esterase reaction shows an ex- treme increase in neutrophilic granulo- cytopoiesis 148 Chapter ... BCR-ABL translocation, the demonstra- tion of low or even negative leukocyte alkaline phosphatase (LAP, see p. 13) w as of key impor- tance. Today the diagnosis is established by det...
Ngày tải lên : 10/08/2014, 08:20
  • 44
  • 321
  • 0
Mollison’s Blood Transfusion in Clinical Medicine - part 4 pot

Mollison’s Blood Transfusion in Clinical Medicine - part 4 pot

... according to their sensitivity to trypsin treatment. The trypsin-sensitive determinants are located on glycophorin A, carrying MN determin- ants, whereas the trypsin-insensitive determinants ... Trypsin cleaves peptides that are C-terminal to lysine and arginine, whereas chymotrypsin catalyses cleavage primarily after the C-terminal of phenylala- nine and tryptophan. Bromelin, ficin and ... wi...
Ngày tải lên : 10/08/2014, 16:23
  • 92
  • 449
  • 0
CURRENT CLINICAL UROLOGY - PART 4 potx

CURRENT CLINICAL UROLOGY - PART 4 potx

... Applied Medical SEAL-005 12-Fr Foley Catheter 18-G, 5-cm-long, 15 F fascial incising needle Cook Urological 090070 INSTRUMENT LIST (Continued ) Item Manufacturer Order no. 18-G, 15-cm-long disposable ... Urological DTN-1 8-1 5.0 5.5-Fr, 40 -cm Kumpe Catheter Cook Urological 023 540 Amplatz Renal Dilator Set Cook Urological 75000 10-mm Nephromax balloon dilator set Boston Scientific: Micro...
Ngày tải lên : 11/08/2014, 01:22
  • 36
  • 227
  • 0
A MANAGER’S GUIDE TO THE DESIGN AND CONDUCT OF CLINICAL TRIALS - PART 4 potx

A MANAGER’S GUIDE TO THE DESIGN AND CONDUCT OF CLINICAL TRIALS - PART 4 potx

... format and organization of reports, for the format and contents of tables, and for the format and naming of files and directories. The CTD provides for analysis of trial data, descriptions of manu- facturing ... design one has to be able to assume that the effect of Treatment A is the same at all levels of the cofactor and in all subgroups. Again...
Ngày tải lên : 14/08/2014, 07:20
  • 26
  • 494
  • 2
CLINICAL INTERVIEWING - PART 4 potx

CLINICAL INTERVIEWING - PART 4 potx

... accumulated clinical experi- ence to evaluate clients’ behavior. Although relying on their own clinical judg- ment can be helpful, it may also be completely misleading because all inter- viewers ... during an interview depends in part on the interview’s purpose and in part on what clinical material is revealed during the interview. An important clinical in- terviewing component th...
Ngày tải lên : 14/08/2014, 07:20
  • 46
  • 176
  • 0
CLINICAL SKILLS - PART 4 pot

CLINICAL SKILLS - PART 4 pot

... understanding. Nearly always due to left hemiphere lesion. N.B. Right- or left-handed? May be right hemisphere lesion if left-handed. – Expressive dysphasia — difficulty finding words; speech slow ... hemianopia 4. Right homonymous hemianopia with macula sparing Eye Eye 1 2 4 3 Optic radiation Optic chiasma Optic nerve Occipital cortex Visual field defects Fig. 7.1 Visual field defects. – non...
Ngày tải lên : 14/08/2014, 07:20
  • 33
  • 238
  • 0
CLINICAL SKILLS - PART 5 potx

CLINICAL SKILLS - PART 5 potx

... Examination of the Nervous System C3 C3 C4 C4 C5 C5 T3T3 T2 T2 T1T1 C8C6 C6 C8 C7 C7 L1 L2 L3 L4 L5 S1 S3 S4 S5 S4 S3 S2 S1 S1 L4 L5 L3 L3 L2 L1 L5 (a) (c) (b) (d) (e) (f) Plate 3: Skin (a) Psoriasis — circumscribed ... walking, ask the patient to do heel-to-toe walking. (Demonstrate it yourself.) There are many examples of abnormal gait. Parkinson’s disease. Stooped pos- ture with most joi...
Ngày tải lên : 14/08/2014, 07:20
  • 33
  • 293
  • 0
Essentials of Clinical Research - part 4 potx

Essentials of Clinical Research - part 4 potx

... promotion. JAMA. Nov 14, 1990; 2 64( 18): 240 9– 241 5. 40 . 21 CFR Part 310 section 502(a) of the Food and Drug Administration Modernization Act of 1997 (Modernization Act) In: Department of Health and Human ... decrease in mortality was most marked in the first 24 months of fol- low-up, with an average follow-up period of 40 months. Therefore, only long-term compliance wit...
Ngày tải lên : 14/08/2014, 11:20
  • 36
  • 353
  • 0
Từ khóa: